PL2123271T3 - Lek do leczenia grypy - Google Patents
Lek do leczenia grypyInfo
- Publication number
- PL2123271T3 PL2123271T3 PL08721158T PL08721158T PL2123271T3 PL 2123271 T3 PL2123271 T3 PL 2123271T3 PL 08721158 T PL08721158 T PL 08721158T PL 08721158 T PL08721158 T PL 08721158T PL 2123271 T3 PL2123271 T3 PL 2123271T3
- Authority
- PL
- Poland
- Prior art keywords
- influenza
- drug
- treatment
- prophylactic
- therapeutic
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 206010022000 influenza Diseases 0.000 title 1
- 206010064097 avian influenza Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000000069 prophylactic effect Effects 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Plant Substances (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007056872 | 2007-03-07 | ||
| PCT/JP2008/053738 WO2008108323A1 (ja) | 2007-03-07 | 2008-03-03 | インフルエンザ治療剤 |
| EP08721158A EP2123271B1 (en) | 2007-03-07 | 2008-03-03 | Drug for treatment of influenza |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2123271T3 true PL2123271T3 (pl) | 2012-03-30 |
Family
ID=39738201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08721158T PL2123271T3 (pl) | 2007-03-07 | 2008-03-03 | Lek do leczenia grypy |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20100204314A1 (pl) |
| EP (1) | EP2123271B1 (pl) |
| JP (2) | JP5286251B2 (pl) |
| KR (1) | KR101473028B1 (pl) |
| CN (1) | CN101715343B (pl) |
| AT (1) | ATE526960T1 (pl) |
| CA (1) | CA2680415A1 (pl) |
| CY (1) | CY1112201T1 (pl) |
| DK (1) | DK2123271T3 (pl) |
| ES (1) | ES2372996T3 (pl) |
| HR (1) | HRP20110861T1 (pl) |
| PL (1) | PL2123271T3 (pl) |
| PT (1) | PT2123271E (pl) |
| SI (1) | SI2123271T1 (pl) |
| TW (1) | TWI424841B (pl) |
| WO (1) | WO2008108323A1 (pl) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7960139B2 (en) | 2007-03-23 | 2011-06-14 | Academia Sinica | Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells |
| JP5986745B2 (ja) | 2008-07-15 | 2016-09-06 | アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ | Ｐｔｆｅ様のアルミニウム・コート・ガラススライド上のグリカンアレイおよび関連する方法 |
| US10087236B2 (en) | 2009-12-02 | 2018-10-02 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
| US11377485B2 (en) | 2009-12-02 | 2022-07-05 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
| WO2011130332A1 (en) | 2010-04-12 | 2011-10-20 | Academia Sinica | Glycan arrays for high throughput screening of viruses |
| EP2568976B1 (en) * | 2010-05-10 | 2015-09-30 | Academia Sinica | Zanamivir phosphonate congeners with anti-influenza activity and determining oseltamivir susceptibility of influenza viruses |
| ES2640001T3 (es) * | 2011-12-16 | 2017-10-31 | Daiichi Sankyo Company, Limited | Procedimiento de producción de un derivado del ácido neuramínico |
| US10130714B2 (en) | 2012-04-14 | 2018-11-20 | Academia Sinica | Enhanced anti-influenza agents conjugated with anti-inflammatory activity |
| WO2014031498A1 (en) | 2012-08-18 | 2014-02-27 | Academia Sinica | Cell-permeable probes for identification and imaging of sialidases |
| US10086054B2 (en) | 2013-06-26 | 2018-10-02 | Academia Sinica | RM2 antigens and use thereof |
| WO2014210564A1 (en) | 2013-06-27 | 2014-12-31 | Academia Sinica | Glycan conjugates and use thereof |
| JP6486368B2 (ja) | 2013-09-06 | 2019-03-20 | アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ | 改変されたグリコシル基を含む糖脂質を用いたヒトｉＮＫＴ細胞の活性化 |
| TW201620939A (zh) | 2014-01-16 | 2016-06-16 | 中央研究院 | 治療及檢測癌症之組合物及方法 |
| US10150818B2 (en) | 2014-01-16 | 2018-12-11 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| EP3129767B1 (en) | 2014-03-27 | 2021-09-01 | Academia Sinica | Reactive labelling compounds and uses thereof |
| KR20170003720A (ko) | 2014-05-27 | 2017-01-09 | 아카데미아 시니카 | 항-ｃｄ20 글리코항체 및 이의 용도 |
| DK3149045T3 (da) | 2014-05-27 | 2023-03-06 | Academia Sinica | Sammensætninger og fremgangsmåder vedrørende universelle glycoformer til forbedret antistofeffekt |
| AU2015267045B2 (en) | 2014-05-27 | 2021-02-25 | Academia Sinica | Anti-HER2 glycoantibodies and uses thereof |
| US10118969B2 (en) | 2014-05-27 | 2018-11-06 | Academia Sinica | Compositions and methods relating to universal glycoforms for enhanced antibody efficacy |
| JP7063538B2 (ja) | 2014-05-28 | 2022-05-09 | アカデミア シニカ | 抗ＴＮＦα糖操作抗体群およびその使用 |
| EP3191500A4 (en) | 2014-09-08 | 2018-04-11 | Academia Sinica | HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS |
| US10495645B2 (en) | 2015-01-16 | 2019-12-03 | Academia Sinica | Cancer markers and methods of use thereof |
| US9975965B2 (en) | 2015-01-16 | 2018-05-22 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| US10342858B2 (en) | 2015-01-24 | 2019-07-09 | Academia Sinica | Glycan conjugates and methods of use thereof |
| AU2017231749A1 (en) | 2016-03-08 | 2018-09-20 | Academia Sinica | Methods for modular synthesis of N-glycans and arrays thereof |
| AU2017316663B2 (en) | 2016-08-22 | 2024-02-22 | CHO Pharma Inc. | Antibodies, binding fragments, and methods of use |
| AU2018349244B2 (en) * | 2017-10-11 | 2024-08-22 | Lifescience As | N-acetylneuraminic acid compositions and methods of use |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE211468T1 (de) * | 1996-07-22 | 2002-01-15 | Sankyo Co | Neuraminsäuredervate, ihre herstellung und medizinische verwendung |
| US6451766B1 (en) * | 1996-07-22 | 2002-09-17 | Sankyo Company, Limited | Neuraminic acid derivatives, their preparation and their medical use |
| JP3209946B2 (ja) * | 1996-07-22 | 2001-09-17 | 三共株式会社 | ノイラミン酸誘導体 |
| US6340702B1 (en) * | 1996-07-22 | 2002-01-22 | Sankyo Company, Limited | Neuraminic acid derivatives, their preparation and their medical use |
| JP4151800B2 (ja) | 1996-08-13 | 2008-09-17 | 第一三共株式会社 | ノイラミン酸化合物 |
| JP3920041B2 (ja) * | 2000-04-25 | 2007-05-30 | 三共株式会社 | ノイラミン酸化合物の水和物及び結晶 |
| TWI291462B (en) * | 2000-04-25 | 2007-12-21 | Daiichi Sankyo Co Ltd | Hydrate crystal of neuraminic acid compound |
| DE602006003600D1 (de) | 2005-08-22 | 2008-12-24 | Delphi Tech Inc | Nockenwellenversteller zur Einstellung der Phase zwischen einer Nockenwelle und einem Antriebsrad |
-
2008
- 2008-03-03 JP JP2009502568A patent/JP5286251B2/ja active Active
- 2008-03-03 ES ES08721158T patent/ES2372996T3/es active Active
- 2008-03-03 SI SI200830440T patent/SI2123271T1/sl unknown
- 2008-03-03 PT PT08721158T patent/PT2123271E/pt unknown
- 2008-03-03 PL PL08721158T patent/PL2123271T3/pl unknown
- 2008-03-03 KR KR1020097018422A patent/KR101473028B1/ko active Active
- 2008-03-03 EP EP08721158A patent/EP2123271B1/en not_active Not-in-force
- 2008-03-03 CA CA002680415A patent/CA2680415A1/en not_active Abandoned
- 2008-03-03 US US12/449,909 patent/US20100204314A1/en not_active Abandoned
- 2008-03-03 HR HR20110861T patent/HRP20110861T1/hr unknown
- 2008-03-03 CN CN2008800149108A patent/CN101715343B/zh active Active
- 2008-03-03 AT AT08721158T patent/ATE526960T1/de active
- 2008-03-03 DK DK08721158.7T patent/DK2123271T3/da active
- 2008-03-03 WO PCT/JP2008/053738 patent/WO2008108323A1/ja not_active Ceased
- 2008-03-07 TW TW097107984A patent/TWI424841B/zh active
-
2011
- 2011-12-30 CY CY20111101293T patent/CY1112201T1/el unknown
-
2013
- 2013-04-22 JP JP2013089202A patent/JP6012076B2/ja active Active
- 2013-08-27 US US14/010,784 patent/US20140018418A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DK2123271T3 (da) | 2012-01-23 |
| KR20090129414A (ko) | 2009-12-16 |
| SI2123271T1 (sl) | 2012-05-31 |
| CY1112201T1 (el) | 2015-12-09 |
| PT2123271E (pt) | 2011-12-20 |
| TW200848018A (en) | 2008-12-16 |
| US20140018418A1 (en) | 2014-01-16 |
| JPWO2008108323A1 (ja) | 2010-06-17 |
| TWI424841B (zh) | 2014-02-01 |
| KR101473028B1 (ko) | 2014-12-15 |
| CA2680415A1 (en) | 2008-09-12 |
| EP2123271B1 (en) | 2011-10-05 |
| CN101715343B (zh) | 2012-09-26 |
| ATE526960T1 (de) | 2011-10-15 |
| CN101715343A (zh) | 2010-05-26 |
| EP2123271A1 (en) | 2009-11-25 |
| ES2372996T3 (es) | 2012-01-30 |
| EP2123271A4 (en) | 2010-03-17 |
| US20100204314A1 (en) | 2010-08-12 |
| HK1137142A1 (en) | 2010-07-23 |
| JP2013139483A (ja) | 2013-07-18 |
| JP5286251B2 (ja) | 2013-09-11 |
| HRP20110861T1 (hr) | 2011-12-31 |
| JP6012076B2 (ja) | 2016-10-25 |
| WO2008108323A1 (ja) | 2008-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI2123271T1 (sl) | Zdravilo za zdravljenje influence | |
| PT2192109E (pt) | Derivado de -aminoácido bicíclico | |
| TW200728307A (en) | Novel spirochromanone derivatives | |
| MX2009006742A (es) | Inhibidores acilaminopirazoles como fgfr. | |
| MX2010004232A (es) | Compuesto de indolina de pirimidilo. | |
| WO2007084728A3 (en) | 2-imino-benzimidazoles | |
| TW200621737A (en) | 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof | |
| MX2009012125A (es) | Compuestos terapeuticos. | |
| TNSN04203A1 (en) | Benzoxazinone-derived compounds, their preparation and use as medicaments | |
| MX2011011776A (es) | Nuevos profarmacos de triptolite. | |
| IL183373A0 (en) | 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof | |
| MXPA06009475A (es) | Derivados de quinazolina y usos terapeuticos de los mismos. | |
| NO20052074L (no) | Substituerte benzoksazinoner og anvendelser derav. | |
| WO2009051223A1 (ja) | 白内障処置のための医薬組成物 | |
| MY138466A (en) | Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders | |
| MX2011012068A (es) | Nucleosidos 2'-fluoro arabino y su utilizaicon. | |
| ZA201007603B (en) | Therapeutic compounds | |
| MY139228A (en) | Imidazolinylmethyl aralkylsulfonamides | |
| TN2012000093A1 (en) | Therapeutic agent for anxiety disorders | |
| MX2010001304A (es) | Compuestos terapeuticos. | |
| IL172290A0 (en) | Use of 2-amino-1-3-propanediol derivatives for the manufacture of a medicament for the treatment of various types of pain | |
| WO2007115020A3 (en) | Therapeutic prostaglandin compounds for the treatment of glaucoma | |
| TW200736236A (en) | Process for the manufacturing of pharmaceutically active compounds | |
| MY201356A (en) | Therapeutic or prophylactic agent for peripheral neuropathies | |
| MX2010004405A (es) | Derivados de pirrolo [1,2-c] imidazol para utilizarse en la profilaxis o tratamiento de cancer que es refractario a terapias cancerigenas conocidas. |